Novel cellular markers in breast cancer: Differential presence of p23K and p30.33K prosomal antigens in tumors of Parsi and non-Parsi women

International Journal of Oncology

Volumn 9, Issue 4, 1996, Pages 669-677

  Bhui, A J ^a,b   Bureau, J P ^b   Abbas, A ^a   Mondal, A ^a   Scherrer, K ^c   Kurkure, A ^d   Therwath, A ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Laboratoire de Physiologie   (France)

^c INSTITUT JACQUES MONOD   (France)

^d BREACH CANDY HOSPITAL   (India)

Author keywords

breast cancer; cellular markers; flow cytometry; prosomes

Indexed keywords

KI 67 ANTIGEN; PROTEIN; PROTEIN P23K; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INDIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029844034     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Barnabas-Sohi NB, Simha MR, Parikh VA, Feuilhade F, Kurkure A, Kouyoumdjian JC, Jussawalla DJ, Doctor VM and Therwath A: Breast carcinoma in a high risk population: Structural alterations in neu, int-2 and p53 genes. Breast Dis 6: 13-26, 1993.
2. Dhingra K and Hortobagyi G: Toward an understanding of predisposition to breast cancer. The emerging molecular epidemiology of breast cancer. Breast Dis 6: 7-11, 1993.
3. Jussawalla DJ, Yeole BB and Natekar MV: An epidemiological study - Cancer incidence in Greater Bombay (By age, sex and ward) 1979-1984. Indian Cancer Society, Bombay 16: 1988.
4. Jussawalla DJ, Subramanyam R and Patel VK: A survey of cancer incidence and sites in different communities of Bombay. Indian J Cancer 312: 761-789, 1979.
5. Schmid HP, Akhayat O, Martins de Sa C, Puvion F, Koehler K and Scherrer K: The prosome: an ubiquitous morphologically distinct RNP particle associated with repressed mRNPs and containing ScRNA and a characteristic set of proteins. EMBO J 3: 29-34, 1984.
6. Scherrer K: Prosomes subcomplexes of untranslated mRNP. Mol Biol Rep 14: 1-9, 1990.
7. Nothwang HG, Coux O, Bey F and Scherrer K: Prosomes and their multicatalytic (MCP) proteinase activity. Eur J Biochem 207: 621-630, 1992.
8. Driscoll J, Brown MG, Finley D and Monaco JJ: MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365: 262-264, 1993.
9. Gaczynska M, Rock KL and Goldberg AL: γ-Interferon and expression of MHC gene regulated peptide hydrolysis by proteasomes. Nature 365: 264-267, 1993.
10. Dahlmann B, Kuehn L, Ishiura S, Tsukahara T, Sugita H, Rivett J, Hough RF, Rechsteiner M, Mykles DL, Fagan JM, Waxman L, Ishii S, Sasaki M, Kloetzel PM, Harris H, Ray K, Behal F J, Demartino GN and McGuire MJ: The multicatalytic proteinase: a high-M(r) endopeptidase. Biochem J 255: 750-775, 1988.
11. Orlowski M and Wilk S: 'Multicatalytic proteinase complex' or 'multicatalytic proteinase: a high-M(r) endopeptidase'. Biochem J 255: 751, 1988.
12. Orlowski M: The multicatalytic protease complex, a major extralysosomal proteolytic system. Biochemistry 29: 10289-10297, 1990.
13. Pal JK, Gounon P, Grossi de Sa MF and Scherrer K: Presence and distribution of specific prosome antigens change as a function of embryonic development and tissue-type Pleurodeles walti. J Cell Sci 90: 555-567, 1988.
14. Kinoshita M, Hamakubo T, Fukui I, Murachi T and Toyohara H: Significant amount of multicatalytic proteinase identified on membrane from human erythrocyte. J Biochem 107: 440-444, 1990.
15. Gautier J, Pal JK, Grossi De Sa MF, Beetschen JC and Scherrer K: Differential cytolocalization of prosomes in axolot during oogenesis and meiotic maturation. J Cell Sci 90: 543-553, 1988.
16. Grossi De Sa MF, Martins de Sa C, Harper F, Olink-Coux M, Huesca M and Scherrer K: The association of prosomes with some of the intermediate filament networks of the animal cells. J Cell Biol 107: 1517-1530, 1988.
17. Kumatori A, Tanaka K, Inamura N, Sone S, Ogura T, Matsumoto T, Tachikawa T, Shin S and Ichihara A: Abnormally high expression of proteasomes in human leukemic cells. Proc Natl Acad Sci USA 87: 7071-7075, 1990.
18. Martins De Sa C, Grossi DE Sa MF, Akhayat O, Broders F, Scherrer K, Horsch A and Schmid HP: Prosomes: ubiquity and inter-species structural variation. J Mol Biol 87: 479-493, 1986.
19. Briane D, Olink-Coux M, Vassy J, Oudar O, Huesca M, Scherrer K and Foucrier J: Immunolocalization of a specific type of prosome close to the bile canaliculi in foetal and adult rat liver. Eur J Cell Biol 57: 30-39, 1992.
20. Grossi De Sa MF, Martins De Sa C, Harper F, Coux O, Akhayat O, Pal JK, Florentin Y and Scherrer K: Cytolocalization of prosomes as a function of differentiation. J Cell Science 89: 151-165, 1988.
21. Bhui AJ, Therwath A, Parikh VA, Simha MR, Olink-CoUX M, Kurkure A, Doctor VM, Scherrer K and Bureau JP: Breast carcinoma in a high-risk population: Modified expression of 25K and 31K prosome antigens. Breast Dis (In press).
22. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ulrich A and McGuire WL: Amplification of the HER-2/neu oncogene correlates with relapse and survival in human breast cancer patients. Breast Cancer Res Treat 5: 117-128, 1985.
23. McGuire WL, Meyer JS, Barlogie B and Kute TE: Impact of flow cytometry on predicting recurrence and survival in breast cancer patients. Breast Cancer Res Treat 5: 177-178, 1985.
24. McGuire WL: Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res Treat 10: 5-9, 1987.
25. Meyer JS: Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma. NCI Monogr 1: 25-28, 1986.
26. Chan PK, Frakes R, Tan EM, Brattain MG, Smetana K and Busch H: Indirect immunofluorescence studies of proliferating cell nuclear antigen in nucleoli of human tumor and normal tissues. Cancer Res 43: 3770-3777; 1983.
27. Freeman JW, Busch PK, Gyorkey F, Gyorkey P, Rosse BE and Busch H: Identification and characterization of a human proliferation associated nucleolar antigen with a molecular weight of 120,000 expressed in early G0/G1 phase. Cancer Res 48: 1244-1251, 1988.
28. Gerdas J, Schwab U, Lemke H and Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13-20, 1983.
29. Bernard NJ, Hall PA, Lemoine NR and Kadar N: Proliferative index in breast carcinoma determined in situ by Ki-67 immunostaining and its relationship to clinical and pathological variables. J Pathol 152: 287-295, 1987.
30. Bacus SS, Goldschmidt R, Chin D, Moran G, Weinberg D and Bacus JW: Biological grading of breast cancer using antibodies to proliferating cells and other markers. Am J Pathol 135: 783-792, 1989.
31. Zehr RJ, Bauer TW, Marks KE and Weltevreden A: Ki-67 and grading of malignant fibrous histocytomas. Cancer 66: 1984-1990, 1990.
32. Pavelic ZP, Pavelic L, Lower EE, Gapany M, Gapany S, Barker EA and Preisler HD: c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma. Cancer Res 52: 2597-2602, 1992.
33. Van Bockstaele DR, Lan J, Snoeck HW, Korthout ML, De Bock RF and Peetermans ME: Aberrant Ki-67 expression in normal bone marrow revealed by multiparameter flow cytometric analysis. Cytometry 12: 50-63, 1991.